Dr. Steven Davis focuses his practice on patent prosecution, portfolio strategy and management, freedom to operate assessments, infringement analysis, patent issues related to IPOs, and intellectual property licensing. He assists universities, start-ups, and major pharmaceutical corporations with protecting technologies in the areas of chemistry, pharmaceuticals, and biotechnology, with a particular emphasis in organic chemistry. Of particular interest is advising venture capital investors with due diligence investigations and advising other clients prior to acquiring intellectual property assets.
Steve has practiced patent law for 23 years both in private practice and as in-house patent counsel for Eli Lilly & Co. His clients also benefit from his experience in industry as a research scientist.
Steve has co-authored eight scientific publications and is a co-inventor on U.S. Patent 5,073,564 covering photo activated insecticides. After completing graduate school, he worked for five years conducting research in the areas of pesticide chemistry and the preparation of compounds containing stable isotopes. Steve is committed to the promotion of early-stage technologies.